ClinicalTrials.Veeva

Menu

Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status and phase

Enrolling
Phase 1

Conditions

Stroke

Treatments

Device: Vibrotactile Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT06244719
23-0783

Details and patient eligibility

About

The goal of this clinical trial is to investigate upper-extremity vibrotactile stimulation with wearables in stroke patients. The main questions it aims to answer are:

Are the wearables well-tolerated by patients? Does the vibrotactile stimulation help regain arm function?

Participants will wear vibrotactile stimulation gloves and shirts for 5 hours daily during their stay at the rehabilitation unit, in addition to conventional therapy. Researchers will compare the treatment group (vibrotactile stimulation wearables) with a control group (conventional therapy only) to see the effects of the vibrotactile stimulation.

Enrollment

24 estimated patients

Sex

All

Ages

50 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Inpatients at rehabilitation units
  • Unilateral left or right sided ischemic stroke within the previous 2 weeks
  • Have Upper-Extremity Fugl-Meyer scores between 6 and 58
  • Have at least 20 degrees of active shoulder elevation and elbow flexion
  • Expected to stay 1-3 weeks in the rehabilitation unit

Exclusion criteria

  • Under anti-spasticity therapy
  • Patients that are dependent on pacemakers
  • Patients that have defibrillators
  • Have lymphedema or AV fistula for dialysis on an arm

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

24 participants in 2 patient groups

Vibrotactile Stimulation
Experimental group
Description:
Participants wear vibrotactile stimulation shirts and gloves for 5 hours per day, 7 days per week, during their stay at the rehabilitation unit, which is expected to be between 2-3 weeks. Participants wear the devices after conventional therapy is done for the day.
Treatment:
Device: Vibrotactile Stimulation
Control
No Intervention group
Description:
Participants undergo conventional therapy only.

Trial documents
1

Trial contacts and locations

2

Loading...

Central trial contact

Mazen Al Borno, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems